King B - Search Results

1

Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials.

King B, Maari C, Lain E, Silverberg JI, Issa M, Holzwarth K, Brinker D, Cardillo T, Nunes FP, Simpson EL. King B, et al. Am J Clin Dermatol. 2021 May;22(3):395-405. doi: 10.1007/s40257-021-00602-x. Epub 2021 Apr 7. Am J Clin Dermatol. 2021. PMID: 33826132 Free PMC article.

2

Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy.

Craiglow BG, King BA. Craiglow BG, et al. JAMA Dermatol. 2015 Oct;151(10):1110-2. doi: 10.1001/jamadermatol.2015.1520. JAMA Dermatol. 2015. PMID: 26107994

3

Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate.

Levy LL, Urban J, King BA. Levy LL, et al. J Am Acad Dermatol. 2015 Sep;73(3):395-9. doi: 10.1016/j.jaad.2015.06.045. Epub 2015 Jul 17. J Am Acad Dermatol. 2015. PMID: 26194706

4

STATing the obvious: it's time for new treatments in atopic dermatitis.

Damsky W, King BA. Damsky W, et al. Among authors: king ba. Br J Dermatol. 2016 Nov;175(5):861-862. doi: 10.1111/bjd.15036. Br J Dermatol. 2016. PMID: 27790697 No abstract available.

5

Tofacitinib for the treatment of alopecia areata and variants in adolescents.

Craiglow BG, Liu LY, King BA. Craiglow BG, et al. J Am Acad Dermatol. 2017 Jan;76(1):29-32. doi: 10.1016/j.jaad.2016.09.006. Epub 2016 Nov 2. J Am Acad Dermatol. 2017. PMID: 27816292

6

Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients.

Liu LY, Craiglow BG, Dai F, King BA. Liu LY, et al. J Am Acad Dermatol. 2017 Jan;76(1):22-28. doi: 10.1016/j.jaad.2016.09.007. Epub 2016 Nov 2. J Am Acad Dermatol. 2017. PMID: 27816293

7

Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib.

King B, Lee AI, Choi J. King B, et al. J Invest Dermatol. 2017 Apr;137(4):951-954. doi: 10.1016/j.jid.2016.10.044. Epub 2016 Nov 22. J Invest Dermatol. 2017. PMID: 27887955 Free PMC article. No abstract available.

8

JAK inhibitors in dermatology: The promise of a new drug class.

Damsky W, King BA. Damsky W, et al. J Am Acad Dermatol. 2017 Apr;76(4):736-744. doi: 10.1016/j.jaad.2016.12.005. Epub 2017 Jan 28. J Am Acad Dermatol. 2017. PMID: 28139263 Free PMC article. Review.

9

Lack of efficacy of apremilast in 9 patients with severe alopecia areata.

Liu LY, King BA. Liu LY, et al. J Am Acad Dermatol. 2017 Oct;77(4):773-774. doi: 10.1016/j.jaad.2017.05.034. J Am Acad Dermatol. 2017. PMID: 28917463 No abstract available.

10

Ruxolitinib for the treatment of severe alopecia areata.

Liu LY, King BA. Liu LY, et al. J Am Acad Dermatol. 2019 Feb;80(2):566-568. doi: 10.1016/j.jaad.2018.08.040. Epub 2018 Sep 6. J Am Acad Dermatol. 2019. PMID: 30195572 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,052 results

Search Page

Filters